A Phase 1 Study of AMG 330 in Subjects With Myeloid Malignancies
Amgen
Amgen
Inmune Bio, Inc.
AbbVie
Sumitomo Pharma America, Inc.
AbbVie
Asana BioSciences
GlaxoSmithKline
Takeda
CureOne
M.D. Anderson Cancer Center
Vanderbilt-Ingram Cancer Center
Masonic Cancer Center, University of Minnesota
University of Utah
Baylor College of Medicine
City of Hope Medical Center
Ariad Pharmaceuticals
Emory University
SCRI Development Innovations, LLC
Vanderbilt-Ingram Cancer Center
Fred Hutchinson Cancer Center